Jin Yang Pharmaceutical Co. Ltd (007370) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.028x

Based on the latest financial reports, Jin Yang Pharmaceutical Co. Ltd (007370) has a cash flow conversion efficiency ratio of 0.028x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.53 Billion ≈ $3.07 Million USD) by net assets (₩159.98 Billion ≈ $108.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 007370 equity to assets ratio to measure how much of total assets are equity-financed.

Jin Yang Pharmaceutical Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Jin Yang Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Jin Yang Pharmaceutical Co. Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Jin Yang Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jin Yang Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Kishin Corporation KO:092440	0.004x
CLOUDR GROUP LTD. F:H3L	N/A
Smr Utama Tbk JK:SMRU	0.656x
City Of London Investment Trust LSE:CTY	0.005x
Jaba I Inversiones Inmobiliarias Socimi SA MC:YABA	0.001x
Inventus Mining Corp V:IVS	4.498x
Software Acquisition Group III Inc NASDAQ:SWAG	-0.174x
360 Capital Mortgage REIT AU:TCF	0.036x

Annual Cash Flow Conversion Efficiency for Jin Yang Pharmaceutical Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Jin Yang Pharmaceutical Co. Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Jin Yang Pharmaceutical Co. Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩159.86 Billion ≈ $108.33 Million	₩1.46 Billion ≈ $992.80K	0.009x	-91.41%
2024-12-31	₩119.88 Billion ≈ $81.24 Million	₩12.79 Billion ≈ $8.67 Million	0.107x	+12.02%
2023-12-31	₩89.58 Billion ≈ $60.71 Million	₩8.53 Billion ≈ $5.78 Million	0.095x	-0.78%
2022-12-31	₩77.58 Billion ≈ $52.57 Million	₩7.45 Billion ≈ $5.05 Million	0.096x	+218.24%
2021-12-31	₩65.32 Billion ≈ $44.26 Million	₩1.97 Billion ≈ $1.34 Million	0.030x	-77.63%
2020-12-31	₩46.31 Billion ≈ $31.38 Million	₩6.24 Billion ≈ $4.23 Million	0.135x	-18.33%
2019-12-31	₩43.67 Billion ≈ $29.59 Million	₩7.21 Billion ≈ $4.89 Million	0.165x	+555.78%
2018-12-31	₩42.05 Billion ≈ $28.50 Million	₩1.06 Billion ≈ $717.38K	0.025x	+208.08%
2017-12-31	₩42.38 Billion ≈ $28.72 Million	₩-987.16 Million ≈ $-668.99K	-0.023x	-8399.26%
2016-12-31	₩49.15 Billion ≈ $33.31 Million	₩-13.47 Million ≈ $-9.13K	0.000x	+99.41%
2015-12-31	₩59.18 Billion ≈ $40.10 Million	₩-2.76 Billion ≈ $-1.87 Million	-0.047x	+7.06%
2014-12-31	₩61.48 Billion ≈ $41.66 Million	₩-3.08 Billion ≈ $-2.09 Million	-0.050x	--

About Jin Yang Pharmaceutical Co. Ltd

KQ:007370 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$36.59 Million

₩53.99 Billion KRW

Market Cap Rank

#23006 Global

#1487 in Korea

Share Price

₩3820.00

Change (1 day)

+4.95%

52-Week Range

₩3440.00 - ₩6090.00

All Time High

₩9262.22